Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues

被引:147
作者
Nagaoka, I
Hirota, S
Niyonsaba, F
Hirata, M
Adachi, Y
Tamura, H
Tanaka, S
Heumann, D
机构
[1] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan
[2] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Sch Pharm, Tokyo, Japan
[3] Seikagaku Corp, Cent Res Labs, Tokyo, Japan
[4] Ctr Hosp Univ Vaudois Lausanne, Div Infect Dis, Lausanne, Switzerland
关键词
D O I
10.1128/CDLI.9.5.972-982.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mammalian myeloid and epithelial cells express various peptide antibiotics (such as defensins and cathelicidins) that contribute to the innate host defense against invading microorganisms. Among these peptides, human cathelicidin CAP18/LL-37 (L-1 to S-37) possesses not only potent antibacterial activity against gram-positive and gram-negative bacteria but also the ability to bind to gram-negative lipopolysaccharide (LPS) and neutralize its biological activities. In this study, to develop peptide derivatives with improved LPS-neutralizing activities, we utilized an 18-mer peptide (K-15; to V-32) of LL-37 as a template and evaluated the activities of modified peptides by using the CD14(+) murine macrophage cell line RAW 264.7 and the murine endotoxin shock model. By replacement of E-16 and K-25 With two L residues, the hydrophobicity of the peptide (18-mer LL) was increased, and by further replacement of Q(22), D-26, and N-30 with three K residues, the cationicity of the peptide (18-mer LLKKK) was enhanced. Among peptide derivatives, 18-mer LLKKK displayed the most powerful LPS- neutralizing activity: it was most potent at binding to LPS, inhibiting the interaction between LPS and LPS-binding protein, and attaching to the CD14 molecule, thereby suppressing the binding of LPS to CD14(+) cells and attenuating production of tumor necrosis factor alpha (TNF-alpha) by these cells. Furthermore, in the murine endotoxin shock model, 18-mer LLKKK most effectively suppressed LPS-induced TNF-alpha production and protected mice from lethal endotoxin shock. Together, these observations indicate that the LPS-neutralizing activities of the amphipathic human CAP18LL-37-derived 18-mer peptide can be augmented by modifying its hydrophobicity and cationicity, and that 18-mer LLKKK is the most potent of the peptide derivatives, with therapeutic potential for gram-negative bacterial endotoxin shock.
引用
收藏
页码:972 / 982
页数:11
相关论文
共 53 条
[41]   Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model [J].
Sawa, T ;
Kurahashi, K ;
Ohara, M ;
Gropper, MA ;
Doshi, V ;
Larrick, JW ;
Wiener-Kronish, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3269-3275
[42]  
Schumann RR, 2000, CHEM IMMUNOL, V74, P42
[43]  
Seydel U, 2000, CHEM IMMUNOL, V74, P5
[44]   The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma [J].
Sorensen, O ;
Bratt, T ;
Johnsen, AH ;
Madsen, MT ;
Borregaard, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22445-22451
[45]  
TOBIAS PS, 1989, J BIOL CHEM, V264, P10867
[46]  
Tossi A, 2000, BIOPOLYMERS, V55, P4
[47]   Role of CCAAT/enhancer-binding protein site in transcription of human neutrophil peptide-1 and-3 defensin genes [J].
Tsutsumi-Ishii, Y ;
Hasebe, T ;
Nagaoka, I .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3264-3273
[48]   Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils [J].
Turner, J ;
Cho, Y ;
Dinh, NN ;
Waring, AJ ;
Lehrer, RI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2206-2214
[49]   Recognition of Gram-negative bacteria and endotoxin by the innate immune system [J].
Ulevitch, RJ ;
Tobias, PS .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (01) :19-22
[50]   PROTECTIVE EFFECTS OF A NOVEL 32-AMINO ACID C-TERMINAL FRAGMENT OF CAP18 IN ENDOTOXEMIC PIGS [J].
VANDERMEER, TJ ;
MENCONI, MJ ;
ZHUANG, J ;
WANG, HL ;
MURTAUGH, R ;
BOUZA, C ;
STEVENS, P ;
FINK, MP .
SURGERY, 1995, 117 (06) :656-662